A novel test enables real-time monitoring of T cells that have been engineered to fight cancer, after re-introduction into the body of a cancer patient. This simple and innovative test provides ...
Lab-developed tests look likely to be removed from FDA oversight. That has to change, writes Walter G. Johnson.